- Home
- VALN vs NDMO Comparison
VALN vs NDMO Comparison
Compare VALN & NDMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VALN
- NDMO
- Stock Information
- Founded
- VALN 2012
- NDMO 2019
- Country
- VALN France
- NDMO United States
- Employees
- VALN N/A
- NDMO N/A
- Industry
- VALN Biotechnology: Biological Products (No Diagnostic Substances)
- NDMO Trusts Except Educational Religious and Charitable
- Sector
- VALN Health Care
- NDMO Finance
- Exchange
- VALN Nasdaq
- NDMO Nasdaq
- Market Cap
- VALN 595.2M
- NDMO 621.8M
- IPO Year
- VALN 2021
- NDMO N/A
- Fundamental
- Price
- VALN $7.44
- NDMO $10.50
- Analyst Decision
- VALN Strong Buy
- NDMO
- Analyst Count
- VALN 2
- NDMO 0
- Target Price
- VALN $17.00
- NDMO N/A
- AVG Volume (30 Days)
- VALN 81.7K
- NDMO 218.6K
- Earning Date
- VALN 03-20-2025
- NDMO 01-01-0001
- Dividend Yield
- VALN N/A
- NDMO 6.75%
- EPS Growth
- VALN N/A
- NDMO N/A
- EPS
- VALN N/A
- NDMO N/A
- Revenue
- VALN $176,817,979.00
- NDMO N/A
- Revenue This Year
- VALN $22.73
- NDMO N/A
- Revenue Next Year
- VALN $11.39
- NDMO N/A
- P/E Ratio
- VALN N/A
- NDMO N/A
- Revenue Growth
- VALN N/A
- NDMO N/A
- 52 Week Low
- VALN $3.62
- NDMO $8.99
- 52 Week High
- VALN $9.50
- NDMO $11.24
- Technical
- Relative Strength Index (RSI)
- VALN 60.56
- NDMO 55.65
- Support Level
- VALN $6.62
- NDMO $10.44
- Resistance Level
- VALN $8.42
- NDMO $10.54
- Average True Range (ATR)
- VALN 0.46
- NDMO 0.08
- MACD
- VALN 0.05
- NDMO -0.01
- Stochastic Oscillator
- VALN 69.85
- NDMO 44.20
About VALN Valneva SE
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates the majority of its revenue from product sales.
About NDMO Nuveen Dynamic Municipal Opportunities Fund of Beneficial Interest
Nuveen Dynamic Municipal Opportunities is a closed-end management investment company. Its investment objective is to seek total return through income exempt from regular federal income taxes and capital appreciation. A majority of its investments are made in municipal securities, the income from which is exempted from regular federal income taxes.